Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 65998
Gene Symbol: C11orf95
C11orf95 		0.500 Biomarker disease HPO
Entrez Id: 5970
Gene Symbol: RELA
RELA 		0.500 Biomarker disease HPO
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.200 Biomarker disease HPO
Entrez Id: 4771
Gene Symbol: NF2
NF2 		0.200 GeneticVariation disease CLINVAR
Entrez Id: 3417
Gene Symbol: IDH1
IDH1 		0.140 Biomarker disease HPO
Entrez Id: 324
Gene Symbol: APC
APC 		0.120 Biomarker disease HPO
Entrez Id: 7249
Gene Symbol: TSC2
TSC2 		0.110 Biomarker disease HPO
Entrez Id: 5395
Gene Symbol: PMS2
PMS2 		0.100 Biomarker disease HPO
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.100 Biomarker disease HPO
Entrez Id: 7248
Gene Symbol: TSC1
TSC1 		0.100 Biomarker disease HPO
Entrez Id: 4292
Gene Symbol: MLH1
MLH1 		0.100 Biomarker disease HPO
Entrez Id: 26040
Gene Symbol: SETBP1
SETBP1 		0.100 Biomarker disease HPO
Entrez Id: 2956
Gene Symbol: MSH6
MSH6 		0.100 Biomarker disease HPO
Entrez Id: 3458
Gene Symbol: IFNG
IFNG 		0.100 Biomarker disease HPO
Entrez Id: 4436
Gene Symbol: MSH2
MSH2 		0.100 Biomarker disease HPO
Entrez Id: 102724428
Gene Symbol: SIK1B
SIK1B 		0.010 AlteredExpression disease BEFREE <i>ROS1</i> fusions in primary glioma and ependymoma were independently corroborated from MSK-IMPACT and Foundation Medicine clinical datasets. 30171048 2018
Entrez Id: 150094
Gene Symbol: SIK1
SIK1 		0.010 AlteredExpression disease BEFREE <i>ROS1</i> fusions in primary glioma and ependymoma were independently corroborated from MSK-IMPACT and Foundation Medicine clinical datasets. 30171048 2018
Entrez Id: 301
Gene Symbol: ANXA1
ANXA1 		0.020 AlteredExpression disease BEFREE Ependymomas and astrocytomas showed significantly higher mean annexin-1 expression levels in the cytoplasm compared with oligodendrogliomas (both: P<0.0001). 19767728 2009
Entrez Id: 10046
Gene Symbol: MAMLD1
MAMLD1 		0.030 GeneticVariation disease BEFREE Ependymoma with YAP1-MAMLD1 fusion is a rare, recently described supratentorial neoplasm of childhood, with few cases published so far. 30246434 2019
Entrez Id: 4193
Gene Symbol: MDM2
MDM2 		0.040 Biomarker disease BEFREE MDM2 gene amplification was found in one ependymoma harbouring wild-type p53. 10231401 1999
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.090 AlteredExpression disease BEFREE P16INK4a expression was not related to anaplasia in oligodendrogliomas and ependymomas. 10564531 1999
Entrez Id: 11186
Gene Symbol: RASSF1
RASSF1 		0.020 PosttranslationalModification disease BEFREE RASSF1A hypermethylation represents the most common gene-specific defect identified in ependymoma highlighting the importance of its further investigation in this disease. 16051033 2005
Entrez Id: 11186
Gene Symbol: RASSF1
RASSF1 		0.020 PosttranslationalModification disease BEFREE RASSF1A was the most frequently methylated gene in both benign tumors (66%) and EP (56%). 16616114 2006
Entrez Id: 5802
Gene Symbol: PTPRS
PTPRS 		0.010 Biomarker disease BEFREE PTPRs, classified with chordoid glioma and separately from ependymomas, showed high expression of SPEDF, KRT18, and genes encoding proteins reported to be expressed in the subcommissural organ, namely ZFH4, RFX3, TTR, and CGRP. 16825954 2006
Entrez Id: 3488
Gene Symbol: IGFBP5
IGFBP5 		0.010 AlteredExpression disease BEFREE IGFBP-5 and IGF-II mRNA levels were significantly increased in ependymomas compared to control cerebellum. 18478565 2008